Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C109 - Chronic Traumatic Encephalopathy

Tuesday 04/05/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Andrew E. Budson, MD
Aging, Dementia, Cognitive, and Behavioral Neurology
Upon completion participants will learn the pathology that defines CTE; understand the interaction between CTE pathology and repetitive head impacts; discover the many secondary pathologies that are often present with CTE pathology; describe the MRI, PET, CSF, and plasma biomarkers that may allow detection of CTE during life; classify patients with possible CTE using the 2021 diagnostic criteria; diagnose & treat patients with possible CTE in clinical practice.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:10 PM PDT Speaker Neuropathology of Chronic Traumatic Encephalopathy and the Role of Repetitive Head Impacts in Multiple Neurodegenerations
Thor D. Stein, MD, PhD
03:30 PM - 03:30 PM PDT Speaker Walk-in Slides
Andrew E. Budson, MD
04:10 PM - 04:50 PM PDT Speaker Can We Detect Chronic Traumatic Encephalopathy During Life Yet? Updates on Imaging and Fluid Biomarkers
Michael Alosco, PHD
04:50 PM - 05:30 PM PDT Speaker Diagnosis and Treatment of Individuals with Possible CTE: What Clinicians Can Do Today
Andrew E. Budson, MD
Faculty Disclosures
Andrew E. Budson, MD Dr. Budson has received personal compensation for serving as an employee of Boston Center for Memory. Dr. Budson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Budson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Budson has received research support from Department of Veterans Affairs. The institution of Dr. Budson has received research support from NIH. The institution of Dr. Budson has received research support from Bristol Myers Squibb. The institution of Dr. Budson has received research support from VoxNeuro. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has received publishing royalties from a publication relating to health care. Dr. Budson has a non-compensated relationship as a Board of Directors/Medical Scientific Advisory Board with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Budson has a non-compensated relationship as a Alzheimer's Advisory Panel with Commonwealth of Massachusetts that is relevant to AAN interests or activities.
Thor D. Stein, MD, PhD Dr. Stein has nothing to disclose.
Michael Alosco, PHD The institution of Michael Alosco, PHD has received research support from NIH.